Skip to main content

Table 1 Description of study population receiving AS/SP or AL treatment

From: A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan

  

Drug

  

AS/SP

AL

Age_years

Mean (95% CI)

17.88 (14.48 – 21.28)

18.45 (14.84 – 22.06)

Temperature Day 0

Mean (95% CI)

37.46 (37.46 – 37.70)

37.59 (37.35 – 37.83)

Sex

Female n (%)

39 (48.8)

47(58.8)

 

Male n (%)

41 (51.2)

33(41.2)